Skip to Main Content

Paper Details

Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.
Cardiovasc Diabetol
3
2022
ACCORD, ASCVD, Diabetes, MI, Sitagliptin, T2DM, atherosclerotic cardiovascular disease, atrial fibrillation, cardiovascular death, chronic kidney disease, heart failure, insulin, myocardial infarction, nonfatal myocardial infarction, nonfatal stroke, participants, patients, stroke, type 2 diabetes mellitus
Author NameAffiliation
Matthew W SegarTexas Heart Institute
Eric D PetersonDuke Clinical Research Institute, Duke University School of Medicine
Eric D PetersonUniversity of Texas Southwestern Medical Center
Eric D PetersonDuke Clinical Research Institute, Duke University School of Medicine
Eric D PetersonUniversity of Texas Southwestern Medical Center
  • 1 - 5

Datasets

Release 1.2